Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Molecules (Basel, Switzerland)|July 9, 2014
Quantification of the resveratrol analogs trans-2,3-dimethoxy-stilbene and trans-3,4-dimethoxystilbene in rat plasma: application to pre-clinical pharmacokinetic studiesShermain Yali Ng, Nunzio Cardullo, Samuel Chao Ming Yeo, et al.Journal of Pharmaceutical and Biomedical Analysis|November 14, 2012
Quantification of trans-2,6-difluoro-4'-N,N-dimethylaminostilbene in rat plasma: application to a pharmacokinetic studyHai-Shu Lin, Vitaliy M Sviripa, David S Watt, et al.Plos One|August 1, 2012
Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcomeJanelle M Hoskins, Pei-Shi Ong, Temitope O Keku, et al.Cancer Letters|September 11, 2021
Celastrol in cancer therapy: Recent developments, challenges and prospectsHannah Ying Lim, Pei Shi Ong, Lingzhi Wang, et al.Patient Preference and Adherence|December 13, 2018
Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative studyJoel Jun Kai Koh, Rui Xiang Cheng, Yicheng Yap, et al.Cancer Letters|May 30, 2021
Resveratrol for cancer therapy: Challenges and future perspectivesBoxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu, et al.Plos One|December 30, 2025
A systematic review of the effectiveness of self-symptoms monitoring with Patient Reported Outcome Measures in rheumatic disease patientsYu Heng Kwan, Livia Oh, Pui Kim Ang, et al.Pharmaceutics|November 11, 2018
A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology DrugsAndrea Li-Ann Wong, Xiaoqiang Xiang, Pei Shi Ong, et al.Oncotarget|March 31, 2016
Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentLingzhi Wang, Do Dang Khoa Phan, Jingwen Zhang, et al.Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.Pageof 3